Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Toons & Teasers
Industry
 Directory
 Toons & Teasers
Quick Links
 Directory
 Job Search
 Toons & Teasers
 Advertising
 
Facilities
 

EquipNet Auction: Cyteir & Moment Biosciences Late Model Lab Instruments - June 14-15

Sign Up for University of Washington Online Master of Pharmaceutical Bioengineering

Our newest cartoon revisits "Milestones in Polio"


Utah Life Science Industry Directory

EquipNet Auction: Former Cyteir Therapeutics and Moment Biosciences Late Model Lab Instruments - June 14-15,  @ 9 am EST

Banner Advertising

Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and delayed by COVID-19, to be launched in 2023 replacing UtahLifeScience.com. Regrettably, we are working with reduced staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved directory upon the launch of the new site. We apologize for the inconvenience.

Recursion Pharmaceuticals, LLC


Recursion Pharmaceuticals, LLC
630 S. Komas Dr, Suite 300
Salt Lake City, UT 84108
Recursion Pharmaceuticals, LLC
 
Phone: (385) 269-0203
Fax: (385) 489-0164
Year Established:  2013
Main Contact: Cristopher C. Gibson, Ph.D., Co-Founder & CEO
 
Other Contacts:  Martin Brenner, CSO
Blake Borgeson, Co-Founder & CTO
 
Company Description
Recursion Pharmaceuticals is a drug discovery company. Recursion uses a novel drug screening platform to efficiently repurpose and reposition drugs to treat rare genetic diseases. Recursion’s novel drug screening platform combines experimental biology and bioinformatics in a massively parallel system to quickly and efficiently identify treatments for multiple rare genetic diseases. The core of the approach revolves around high-throughput automated screening using high-content assays in human cells, which allows the near simultaneous modeling of hundreds of genetic diseases. Rich data from these assays is probed using advanced statistical and machine learning approaches, and the effects of thousands of known drugs and shelved drug candidates can be investigated efficiently to identify those holding the most promise for the treatment of any one rare genetic disease.


Main Industry Directory

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2023 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

UtahLifeScience.com is owned and published by Info.Resource, Inc.